Yield10 Bioscience Signs Research Agreement with GDM to Evaluate New Yield Traits in Soybean
August 11 2020 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company, today announced that it has signed a three-year
non-exclusive research agreement with GDM (“GDM”), a company
specialized in plant genetics based in Gibson City, Illinois to
evaluate novel yield traits in soybean.
Under the agreement, GDM plans to work with Yield10 yield traits
within its research and development program for soybean as a
strategy to improve soybean yield performance and sustainability.
The research agreement includes three novel crop yield traits
in the first phase with the potential to expand the program to more
traits in the future. In greenhouse and/or field tests performed by
Yield10 to date, these novel traits have shown a range of promising
activities relevant to soybean such as improved vigor, increased
photosynthesis and/or increased seed yield.
Both Yield10 and GDM intend to explore forming a broader
collaboration to leverage Yield10’s GRAIN trait gene discovery
platform and GDM’s rapid trait editing capabilities in elite
varieties for the discovery, development and launch of novel
soybean performance traits.
“Yield10’s unique approach to trait discovery utilizing its
‘Trait Factory’ has produced a significant portfolio of yield
traits with promising activities that are appealing to us for
testing in our elite soybean germplasm,” said André Beló, Ph.D.,
New Breeding Techniques Manager at GDM. “GDM uses advanced research
and breeding technologies, such as genome editing and genome
selection and we believe there may be significant opportunities to
develop new performance traits to complement our capabilities in
plant breeding. We look forward to working with the Yield10 team to
develop new varieties of high yielding soybean.”
Kristi Snell, Chief Science Officer of Yield10 Bioscience
commented, “We look forward to supporting the research team at GDM
as we enable their evaluation of new traits in soybean. Yield10 has
demonstrated capability using our GRAIN platform to identify novel
traits that exhibit significant potential for producing yield
benefits in soybean and other oilseed crops. This partnership with
GDM will provide insights critical to improving the performance of
soybean.”
“Working with major companies like GDM that lead innovation in
the agriculture sector to test new traits identified using our
Trait Factory in crops like soybean is fundamental to our strategy
of creating option value for our traits in the major crops,” said
Oliver Peoples, Ph.D., President and Chief Executive Officer of
Yield10 Bioscience. “In addition to its North American seed
operations, GDM has extensive research, plant breeding, testing and
crop development operations in Argentina and Brazil, which may
provide a path to rapid commercial deployment. We are very pleased
to have GDM engaged testing our traits in their germplasm and
anticipate continuing to explore ways of working together more
broadly in the development of additional performance traits in
soybean.”
About GDM
GDM is a global group that applies state-of-the-art technology
to research, develop and commercialize maximum productivity soybean
varieties and other crops. GDM employs 750 professionals, has
operations in 16 countries, 13 R&D centers and an extensive
testing location network throughout the world. Headquartered in
Gibson City, Illinois, GDM North America commercializes its leading
genetics through its brands DONMARIO seeds, Virtue Seeds and its
third-party licensing business. Additionally, in 2019, GDM entered
a joint venture with Mustang Seeds.
To learn more about GDM please visit www.GDMseeds.com.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
developing crop innovations to improve crop yields and enhance
sustainable global food security. The Company utilizes its
proprietary “GRAIN“ (Gene Ranking Artificial Intelligence Network)
gene discovery platform to identify gene targets to improve yield
performance and value in major commercial food and feed crops.
Yield10 uses its Camelina oilseed platform to rapidly evaluate and
field test new trait leads enabling the translation of promising
new traits into the major commercial crops. As a path toward
commercialization, Yield10 is pursuing a partnering approach with
agricultural companies to drive new traits into development in
crops such as canola, soybean and corn. The Company is also
developing Camelina as a platform crop for producing nutritional
oils and specialty products such as PHA biomaterials for use in
water treatment applications. Yield10 is headquartered in Woburn,
MA and has an Oilseeds Center of Excellence in Saskatoon,
Canada.
For more information about Yield10 Bioscience, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, that Yield10 and GDM intend to explore forming a
broader collaboration for traits in soybean, that the traits
developed by Yield10 may contribute to new solutions to meet
growing global food demand by boosting crop performance, that
Yield10 traits have significant potential for producing yield
benefits in soybean, and that the data generated in the GDM program
will help Yield10 continue to characterize the activity of its
traits across a range of crop plants, constitute
forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Yield10
Bioscience's filings with the Securities and Exchange Commission.
Yield10 assumes no obligation to update any forward-looking
information contained in this press release or with respect to the
matters described herein.
Contacts: GDM:Maria
Soledad Echagüe, +54 (9 11) 3243-1381, sechague@gdmseeds.com
Yield10
Bioscience:Lynne H.
Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (516) 222-2560,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Sep 2023 to Sep 2024